RARA CRAFT DATABASE for FDA Medical Devices
510(k)K202768

FDA DEVICE FACTS

KOSMO Femoral Stem

B-One Ortho, Corp.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 1, 2021PRODUCT CODELZO

Indications for use

T he b-ONE TM Total Hip System is intended for primary or revision total hip replacement in skeletally mature patients wit h a severely disabled h ip joint and/or hip damage due to the following conditions: Osteoarthritis, traumatic arthritis, avascular necrosis of the femoral head, noninflammatory degenerative joint disease (NI D JD), slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant. H ip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis and congenital dysplasia; treatmen ts of nonunion, acute traumatic fracture o f the femoral head or neck; failed endoprosthesis, femoral osteotomy, or Gi rdlestone resection; and fracture-dislocation of the hip. The b-ONE TM Total Hip System KOSMO TM HA coated st ems are intended for cementless use only. The b-ONETM Total Hip System KOSMOTM stainless steel stems are intended for cemented use only. b-ONE TM Total Hip System components are not intended for use with other total hip systems.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026